Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar Foxyprox (85.98) Submitted: 2/12/2008 4:37:15 PM : Outperform Start Price: $6.58 SLXP Score: +671.88

Highly undervaled, great bargain in long run.

Featured Broker Partners


Advertisement